Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

79.88 -0.12 (-0.15%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Where ANI Pharmaceuticals Stands With Analysts ↗
 
Via Benzinga
News headline image
Looking Into ANI Pharmaceuticals's Return On Capital Employed ↗
 
Via Benzinga
News headline image
ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
Why ANI Pharmaceuticals Stock Is Soaring Today ↗
ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q1 revenues were $106.8 million, +65.6% Y/Y, beating the  
Via Benzinga
News headline image
Earnings Preview For ANI Pharmaceuticals ↗
 
Via Benzinga
News headline image
ANI Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
Stocks Reverse Gains Ahead Of Slew Of Inflation Data ↗
Stocks are lower this afternoon, as investors await a deluge of inflation data amid a rally for the banking sector. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China. 
Via Benzinga
News headline image
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗
 
Via Benzinga
News headline image
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
Organon Stock Scores Market Leadership With Jump To 83 RS Rating ↗
Organon sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
News headline image
ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET
From ANI Pharmaceuticals, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.